Kim and colleagues reported that peripheral BDNF levels in AD patients initially increase in the early stages of the disease compared with healthy, age- and sex-matched controls, and then decrease in patients with moderate or severe AD [21]. The gene discussed is BDNF; the disease is Alzheimer disease.